Evidence map›Paper›PMID 22732871›Full record

ArticleGastrointestinal endoscopy2012

Sex and racial disparities in duodenal biopsy to evaluate for celiac disease.

Benjamin Lebwohl, Christina A Tennyson, Jennifer L Holub, David A Lieberman, Alfred I Neugut, Peter H R Green

Abstract readEvaluation Study
In one paragraph

Article in Gastrointestinal endoscopy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Guideline
  2. ACG clinical guidelines: diagnosis and management of celiac disease.The American journal of gastroenterology · 2013
    Guideline
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Celiac Disease in the Elderly.Current treatment options in gastroenterology · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Coeliac disease: to biopsy or not?Nature reviews. Gastroenterology & hepatology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Benjamin LebwohlCeliac Disease Center, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Christina A Tennyson
Jennifer L Holub
David A Lieberman
Alfred I Neugut
Peter H R Green
Columbia University Irving Medical Center · USOregon Health & Science University · USColumbia University · US

Funding

National Endoscopic Database of the Clinical Outcomes Research InitiativeU01DK057132 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI LIEBERMAN, DAVID A · 1999 to 2014
$12.7M
CTSA: K12 COMPONENTKL2RR024157 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$8.9M
NCRR NIH HHS KL2 RR024157NIDDK NIH HHS U01 DK057132NIDDK NIH HHS U01DK57132
6 · The paper itself

Abstract

backgroundCeliac disease (CD) is common but underdiagnosed in the United States. Serological screening studies indicate that, although CD occurs at the same frequency in both sexes, women are diagnosed more frequently than men (2:1). CD is less frequently diagnosed among black patients, though the seroprevalence in this group is not known.

objectiveTo measure the rates of duodenal biopsy during EGD for symptoms consistent with CD.

designRetrospective cohort study.

settingClinical Outcomes Research Initiative National Endoscopy Database, spanning the years 2004 through 2009. PATIENTS: Adults undergoing EGD for the indication of diarrhea, anemia, iron deficiency, or weight loss, in which the endoscopic appearance of the upper GI tract was normal. MAIN OUTCOME MEASUREMENT: Performance of duodenal biopsy.

resultsOf 13,091 individuals (58% female patients, 9% black patients) who met the inclusion criteria, duodenal biopsy was performed in 43%, 45% of female patients and 39% of male patients (P < .0001). Black patients underwent duodenal biopsy in 28% of EGDs performed compared with 44% for white patients (P < .0001). On multivariate analysis, male sex (odds ratio [OR] 0.81; 95% CI, 0.75-0.88), older age (OR for 70 years and older compared with 20-49 years, 0.51; 95% CI, 0.46-0.57), and black patients (OR 0.55; 95% CI, 0.48-0.64) were associated with decreased odds of duodenal biopsy. LIMITATIONS: Lack of histopathologic correlation with CD prevalence.

conclusionsIn this multiregional endoscopy database spanning the period from 2004 through 2009, rates of duodenal biopsy increased modestly over time, but overall remained low in patients with possible clinical indications for biopsy. Nonperformance of duodenal biopsy during endoscopy may be contributing to the underdiagnosis of CD in the United States.

Indexed as

Black or African AmericanWhite PeopleAdultAgedAged, 80 and overAge FactorsBiopsyCeliac DiseaseCohort StudiesCross-Sectional StudiesDatabases, FactualDuodenumEndoscopy, Digestive SystemFemaleHealthcare DisparitiesHumans

Identifiers

PMID22732871
PMCPMC3445758
OpenAlexW2152473522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.